Статья
БИОЛОГИЧЕСКАЯ ИСКУССТВЕННАЯ ПЕЧЕНЬ
Печеночная недостаточность является важнейшим жизнеугрожающим состоянием, ассоциирующимся с высочайшей степенью смертности. В обзоре приводятся основные направления по искусственному замещению функций печени, делается акцент на теоретических и практических возможностях создания биологической искусственной печени, разделов оптимизации: модификации мембран, выбора клеток для протезирования функции и создания благоприятной биологической среды для функционирования клеток.
1. A biological extracorporeal metabolic device for hepatic support / I. Koshino// Trans. Amer. Soc. Artif. Intern. Organs. 1975. Vol. 21. P. 492.
2. A comparative study of proliferation and hepatic differentiation of human adipose-derived stem cells / R. Coradeghini// Cells Tissues Organs. 2010. Vol. 191. P. 466–477.
3. A reversibly immortalized human hepatocyte cell line as a source of hepatocyte-based biological support / N. Kobayashi// Addict Biol. 2001. Vol. 6. P. 293–300.
4. A tightly regulated immortalized human fetal hepatocyte cell line to develop a bioartificial liver / N. Kobayashi// Transplant. Proc. 2001. Vol. 33. P. 1948–1949.
5. Adham M. Extracorporeal liver support: waiting for the deciding vote // ASAIO J. 2003. Vol. 49. P. 621–632.
6. Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes / A. Banas// Hepatology. 2007. Vol. 46. P. 219–228.
7. Alginate-encapsulated HepG2 cells in a fluidized bed bioreactor maintain function in human liver failure plasma / S. M. Coward// Artif. Organs. 2009. Vol. 33. P. 1117–1126.
8. Alginate-encapsulated human hepatoblastoma cells in an extracorporeal perfusion system improve some systemic parameters of liver failure in a xenogeneic model / T. M. Rahman// Artif. Organs. 2004. Vol. 28 P. 476–482.
9. Artificial and bioartificial support systems for acute and acute-on-chronic liver failure: a systematic review / L. L. Jaergard// JAMA. 2003. Vol. 289. P. 217–222.
10. Artificial liver support devices for fulminant liver failure / A. Sechser// Clin. Liver. Dis. 2001. Vol. 5. P. 415–430.
11. Bioartificial liver support: report of the longest continuous treatment with human hepatocytes / J. M. Millis// Transplant. Proc. 2001. Vol. 33. P. 1935.
12. Biochemical and molecular characterization of hepatocytelike cells derived from human bone marrow mesenchymal stem cells on a novel three-dimensional biocompatible nanofibrous scaffold / S. Kazemnejad// J. Gastroenterol. Hepatol. 2009. Vol. 24. P. 278–287.
13. Bridging a patient with acute liver failure to liver transplantation by the AMC-bioartificial liver / M. P. van de Kerkhove// Cell Transplant. 2003. Vol. 12. P. 563–568.
14. Brunner G., Holloway C. J., Lösgen H. The application of immobilized enzymes in an artificial liver support system // Artif. Organs. 1979. Vol. 3. P. 27–30.
15. Brunner G., Tegtimeier F. Enzymatic detoxification using lipophilic hollow fiber membranes // Artif. Organs. 1984. Vol. 8. P. 161–166.
16. Caron J. M., Bissel D. M. Extracellular matrix induces albumin gene expression in cultured rat hepatocytes // Hepatology. 1989. Vol. 10 (4). P. 636.
17. Carpentier B., Gautier A., Legallais C. Artificial and bioartificial liver devices: present and future // Gut. 2009. Vol. 58. P. 1690–1702.
18. Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis / C. Natanson// JAMA. 2008. Vol. 299. P. 2304–2312.
19. Cell-free supernatant from hepatocyte cultures improves survival of rats with chemically induced acute liver failure / P. LaPlante-O’Neill// J. Surg. Res. 1982. Vol. 32. P. 347.
20. Cells for bioartificial liver devices: the human hepatomaderived cell line C3A produces urea but does not detoxify ammonia / D. Mavri-Damelin// Biotechnol. Bioeng. 2008. Vol. 99. P. 644–651.
21. Chamuleau R. A., Deurholt T., Hoekstra R. Which are the right cells to be used in a bioartificial liver? // Metab. Brain. Dis. 2005. Vol. 20. P. 327–335.
22. Chamuleau R. A. Future of bioartificial liver support // World J. Gastrointest. Surg. 2009. Vol. 1. P. 21–25.
23. Chang T. M. S. Experience with the treatment of acute liver failure patients by hemoperfusion over biocompatible microencapsulated (coated) charcoal // Artificial Liver Support / I. M. Murray-Lyon (eds), R. Williams. England. Tunbridge Wells: Pitman Medical, 1975. 367 p.
24. Chen G., Palmer A. F. Hemoglobin-based oxygen carrier and convection enhanced oxygen transport in a hollow fiber bioreactor // Biotechnol. Bioeng. 2009. Vol. 102. P. 1603–1612.
25. Chen G., Palmer A. F. Mixtures of hemoglobin-based oxygen carriers and perfluorocarbons exhibit a synergistic effect in oxygenating hepatic hollow fiber bioreactors // Biotechnol. Bioeng. 2010. Vol. 105. P. 534–542.
26. Chen G., Palmer A. F. Perfluorocarbon facilitated O2 transport in a hepatic hollow fiber bioreactor // Biotechnol. Prog. 2009. Vol. 25. P. 1317–1321.
27. Clinical application of bioartificial liver support systems / M. P. van de Kerkhove// Ann. Surg. 2004. Vol. 240. P. 216–230.
28. Clinical extracorporeal hybrid liver support-phase I study with primary porcine liver cells / I. M. Sauer// Xenotransplantation. 2003. Vol. 10. P. 460–469.
29. Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells / O. Parolini// Stem. Cells. 2008. Vol. 26. P. 300–311.
30. Cowan P. J., d’Apice A. J. The coagulation barrier in xenotransplantation: incompatibilities and strategies to overcome them // Curr. Opin. Organ. Transplant. 2008. Vol. 13 P. 178–183.
31. Cultivation of immortalized human hepatocytes HepZ on macroporous CultiSpher G microcarriers / A. Werner// Biotechnol. Bioeng. 2000. Vol. 68. P. 59–70.
32. Dan Y. Y., Yeoh G. C. Liver stem cells: a scientific and clinical perspective // J. Gastroenterol. Hepatol. 2008. Vol. 23. P. 687–698.
33. Demetriou A. A. Hepatic assist devices // Panminerva Med. 2005. Vol. 47. P. 31–37.
34. Development of a bioartificial liver: Properties and function of a hollow-fiber module inoculated with liver cells / J. Rozga// Hepatology. 1993. Vol. 17. P. 258.
35. Differentiating characterization of human umbilical cord blood-derived mesenchymal stem cells in vitro / X. Q. Kang// Cell .Biol. Int. 2006. Vol. 30. P. 569–575.
36. Differentiation and transplantation of human induced pluripotent stem cell- derived hepatocyte-like cells / S. Asgari// Stem. Cel.l Rev. 2013. Vol. 9 (4). P. 493–504. DOI 10.1007/s 12015-011-9330y
37. Differentiation of human adipose stromal cells into hepatic lineage in vitro and in vivo / M. J. Seo// Biochem. Biophys. Res. Commun. 2005. Vol. 328. P. 258–264.
38. Differentiation of human embryonic stem cells into hepatocytes in 2D and 3D culture systems in vitro / H. Baharvand// Int. J. Dev. Biol. 2006. Vol. 50. P. 645–652.
39. Differentiation of human umbilical cord mesenchymal stromal cells into low immunogenic hepatocyte-like cells / Q. Zhao// Cytotherapy. 2009. Vol. 11. P. 414–426.
40. Differentiation of mesenchymal cells derived from human amniotic membranes into hepatocyte-like cells in vitro / T. Tamagawa// Hum. Cell. 2007. Vol. 20. P. 77–84.
41. Ding Y. T., Shi X. L. Bioartificial liver devices: Perspectives on the state of the art // Front. Med. 2011. Vol. 5. P. 15–19.
42. Donato M. T., Castell J. V., Gómez-Lechón M. J. Characterization of drug metabolizing activities in pig hepatocytes for use in bioartificial liver devices: comparison with other hepatic cellular models // J. Hepatol. 1999. Vol. 31. P. 542–549.
43. Early clinical experience with a hybrid bioartificial liver / A. A. Demetriou// Scand. J. Gastroenterol. 1995 (Suppl). Vol. 208. P.111–117.
44. Early experiences with a porcine hepatocyte-based bioartificial liver in acute hepatic failure patients / E. Morsiani// Int. J. Artif. Organs. 2002. Vol. 25. P. 192–202.
45. Effect of human patient plasma ex vivo treatment on gene expression and progenitor cell activation of primary human liver cells in multi-compartment 3D perfusion bioreactors for extra-corporeal liver support / E. Schmelzer// Biotechnol. Bioeng. 2009. Vol. 103. P. 817–827.
46. Effect of human umbilical cord blood-derived mesenchymal stem cells in a cirrhotic rat model / K. H. Jung// Liver Int. 2009. Vol. 29. P. 898–909.
47. Effects of artificial liver support system on patients with acute or chronic liver failure / W. B. Du// Transplant. Proc. 2005. Vol. 37. P. 4359–4364.
48. Enhanced functions of human embryonic stem cell-derived hepatocyte-like cells on three-dimensional nanofibrillar surfaces / Z. Farzaneh// Stem. Cell. Rev. 2010. Vol. 6 P. 601–610.
49. Establishment of a highly differentiated immortalized human hepatocyte cell line as a source of hepatic function in the bioartificial liver / N. Kobayashi// Transplant. Proc. 2000. Vol. 132. P. 237–241.
50. Evaluation of a new immortalized human fetal liver cell line (cBAL111) for application in bioartificial liver / P. P. Poyck// J. Hepatol. 2008. Vol. 48. P. 266–275.
51. Ex vivo characteristics of human amniotic membranederived stem cells / J. Kim// Cloning Stem Cells. 2007. Vol. 9. P. 581–594.
52. Extracorporeal bioartificial liver using the radial-flow bioreactor in treatment of fatal experimental hepatic encephalopathy / H. Kanai// Artif. Organs. 2007. Vol. 31. P. 148–151.
53. Fausto N. Liver regeneration and repair: hepatocytes, progenitor cells, and stem cells // Hepatology. 2004. Vol. 39. P. 1477–1487.
54. First clinical use of a novel bioartificial liver support system (BLSS) / G. V. Mazariegos// Am. J. Transplant. 2002. Vol. 2. P. 260–266.
55. Formation of multicellular spheroids composed of adult rat hepatocytes in dishes with positively charged surfaces and under other nonadherent environments / N. H. Koide// Exper. Cell. Res. 1990. Vol. 186. P. 227.
56. Hay P. D., Veitch A. R., Gaylor J. D. Oxygen transfer in a convection-enhanced hollow fiber bioartificial liver // Artif. Organs. 2001. Vol. 25. P. 119–130.
57. Hepatic differentiation from human mesenchymal stem cells on a novel nanofiber scaffold / M. Ghaedi// Cell. Mol. Biol. Lett. 2012. Vol. 17. P. 89–106.
58. Hepatic differentiation of amniotic epithelial cells / F. Marongiu// Hepatology. 2011. Vol. 53. P. 1719–1729.
59. Hepatic stem cells: from inside and outside the liver? / M. R. Alison// Cell. Prolif. 2004. Vol. 37. P. 1–21.
60. Hepatogenesis of adipose-derived stem cells on polylactidecoglycolide scaffolds: in vitro and in vivo studies / M. Wang// Tissue. Eng. Part. C. Methods. 2010. Vol. 16. P. 1041–1050.
61. Hepatogenic differentiation of human mesenchymal stem cells from adipose tissue in comparison with bone marrow mesenchymal stem cells / R. Taléns-Visconti// World J. Gastroenterol. 2006. Vol. 12. P. 5834–5845.
62. Human hepatocyte functions in a crossed hollow fiber membrane bioreactor / L. De Bartolo// Biomaterials. 2009. Vol. 30. P. 2531–2543.
63. Human umbilical cord matrix stem cells efficiently rescue acute liver failure through paracrine effects rather than hepatic differentiation / S. Zhang// Tissue. Eng. Part. A. 2012. Vol. 18. P. 1352–1364.
64. In vitro assessment of encapsulated C3A hepatocytes functions in a fluidized bed bioreactor / B. David// Biotechnol. Prog. 2004. Vol. 20. Р. 1204–1212.
65. In vitro differentiation of human umbilical cord bloodderived mesenchymal stem cells into hepatocyte-like cells / S. H. Hong// Biochem. Biophys. Res. Commun. 2005. Vol. 330. P. 1153–1161.
66. In vitro hepatic differentiation of human mesenchymal stem cells / K. D. Lee// Hepatology. 2004. Vol. 40. P. 1275–1284.
67. In vivo hepatic differentiation of mesenchymal stem cells from human umbilical cord blood after transplantation into mice with liver injury / J. Yu// Biochem. Biophys. Res. Commun. 2012. Vol. 422. P. 539–545.
68. In-depth physiological characterization of primary human hepatocytes in a 3D hollow-fiber bioreactor / D. Mueller// J. Tissue. Eng. Regen. Med. 2011. Vol. 5. P. e207–218.
69. Induced pluripotent stem cells: a new era for hepatology / S. Asgari// J. Hepatol. 2010. Vol. 53. Р. 738–751.
70. Inducing proliferation of human amniotic epithelial (HAE) cells for cell therapy / S. Terada// Cell. Transplant. 2000. Vol. 9. P. 701–704.
71. Initial experience with the modified extracorporeal liver-assist device for patients with fulminant hepatic failure: system modifications and clinical impact / J. M. Millis// Transplantation. 2002. Vol. 74. P. 1735–1746.
72. Isolation and characterization of a stem cell population from adult human liver / M. B. Herrera// Stem. Cells. 2006. Vol. 24. P. 2840–2850.
73. Isolation and characterization of adult human liver progenitors from ischemic liver tissue derived from therapeutic hepatectomies / H. Stachelscheid// Tissue. Eng. Part. A. 2009. Vol. 15. P. 1633–1643.
74. Isolation and characterization of stem cells from the placenta and the umbilical cord / C. M. Mihu// Rom. J. Morphol. Embryol. 2008. Vol. 49. P. 441–446.
75. Isolation of human progenitor liver epithelial cells with extensive replication capacity and differentiation into mature hepatocytes / H. Malhi// J. Cell. Sci. 2002. Vol. 115. P. 2679–2688.
76. Isolation of multipotent mesenchymal stem cells from umbilical cord blood / O. K. Lee// Blood. 2004. Vol. 103. P. 1669–1675.
77. Isolation, characterization, and differentiation to hepatocytelike cells of nonparenchymal epithelial cells from adult human liver / C. Duret// Stem. Cells. 2007. Vol. 25. P. 1779–1790.
78. Jauregui H. O., Muller T. E. Long-term cultures of adult mammalian hepatocytes in hollow fibers as the cellular component of extracorporeal (hybrid) liver assist devices // Artif. Organs. 1992. Vol. 16 (2). P. 209.
79. Jauregui H. O. Treatment of hepatic insufficiency based on cellular therapies // Int. J. Artif. Organs. 1991. Vol. 14. P. 407.
80. Jung Y., Bauer G., Nolta J. A. Concise review: Induced pluripotent stem cell-derived mesenchymal stem cells: progress toward safe clinical products // Stem. Cells. 2012. Vol. 30. P. 42–47.
81. Large-pore hemodialytic procedures in pigs with ischemic hepatic necrosis; a randomized study / G. H. De Groot// Hepato-gastroenterology. 1984. Vol. 31 (6). P. 254–260.
82. Liver support systems / A. Santoro// Contrib. Nephrol. 2007. Vol. 156. P. 396–404.
83. Manufacturing of human placenta-derived mesenchymal stem cells for clinical trials / G. Brooke// Br. J. Haematol. 2009. Vol. 144. Р. 571–579.
84. Matikainen T., Laine J. Placenta-an alternative source of stem cells // Toxicol. Appl. Pharmacol. 2005. Vol. 207. P. 544–549.
85. McKenzie T. J., Lillegard J. B., Nyberg S. L. Artificial and bioartificial liver support // Semin. Liver. Dis. 2008. Vol. 28. P. 210–217.
86. Miki T., Ring A., Gerlach J. Hepatic differentiation of human embryonic stem cells is promoted by three-dimensional dynamic perfusion culture conditions // Tissue. Eng. Part. C. Methods. 2011. Vol. 17. P. 557–568.
87. Mullon C., Pitkin Z. The HepatAssist bioartificial liver support system: clinical study and pig hepatocyte process // Expert. Opin. Investig. Drugs. 1999. Vol. 8. P. 229–235.
88. Naik S., Santangini H., Jauregui H. O. Culture of adults rabbit hepatoctyes in perfused hollow membranes // In Vitro Cell. Dev. Biol. 1990. Vol. 26. P. 107.
89. Neonatal hepatocyte culture on artificial capillaries: A model for drug metabolism and the artificial liver / J. C. Hager// ASAIO. J. 1983. Vol. 6. P. 26–35.
90. Neurological improvement during bioartificial liver sessions in patients with acute liver failure awaiting transplantation / D. Samuel// Transplantation. 2002. Vol. 73. P. 257–264.
91. Novel bioartificial liver support system: preclinical evaluation / J. F. Patzer// Ann. N. Y. Acad. Sci. 1999. Vol. 875. P. 340–352.
92. Origin and characterization of a human bipotent liver progenitor cell line / R. Parent// Gastroenterology. 2004. Vol. 126. P. 1147–1156.
93. Phase I clinical trial with the AMC-bioartificial liver / A. Belli// Int. J. Artif. Organs. 2002. Vol. 25. P. 950–959.
94. Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure / A. J. Ellis// Hepatology. 1996. Vol. 24. P. 1446–1451.
95. Pitkin Z., Mullon C. Evidence of absence of porcine endogenous retrovirus (PERV) infection in patients treated with a bioartificial liver support system // Artif. Organs. 1999. Vol. 23. P. 829–833.
96. Pless G. Artificial and bioartificial liver support // Organogenesis. 2007. Vol. 3. P. 20–24.
97. Polson J., Lee W. M. American Association for the Study of Liver Disease. AASLD position paper: the management of acute liver failure // Hepatology. 2005. Vol. 41 P. 1179–1197.
98. Primary cultures of rat hepatocytes in hollow fiber chambers / H. O. Jauregui// In Vitro Cell. Dev. BIol. 1994. Vol. 30A. P. 23–29.
99. Progress and future challenges in stem cell-derived liver technologies / D. M. Dalgetty// Am. J. Physiol. Gastrointest. Liver. Physiol. 2009. Vol. 297. P. G241–248.
100. Prolongation of survival of pigs with ischemic liver failure by treatment with a bioartificial liver using glutamine synthetase transfected recombinant HepG2 / S. Enosawa// Transplant. Proc. 2001. Vol. 33. P. 1945–1947.
101. Promoter-defined isolation and identification of hepatic progenitor cells from the human fetal liver / P. Wang// Histochem. Cell. Biol. 2008. Vol. 130. P. 375–385.
102. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure / A. A. Demetriou// Ann. Surg. 2004. Vol. 239. P. 660–667.
103. Rapid generation of mature hepatocyte-like cells from human induced pluripotent stem cells by an efficient three-step protocol / Y. F. Chen // Hepatology. 2012. Vol. 55. P. 1193–1203.
104. Recovery of preservation-injured primary human hepatocytes and nonparenchymal cells to tissue like structures in large-scale bioreactors for liver support: an initial transmission electron microscopy study / J. C. Gerlach// J. Invest. Surg. 2003. Vol. 16. P. 83–92.
105. Remy B., Deby-Dupont G., Lamy M. Red blood cell substitutes: fluorocarbon emulsions and haemoglobin solutions. // Br. Med. Bull. 1999. Vol. 55. P. 277–298.
106. Reprogramming of human somatic cells to pluripotency with defined factors / I. H. Park// Nature. 2008. Vol. 451. P. 141–146.
107. Reversal of fulminant hepatic failure using an extracorporeal liver assist device / N. L. Sussman// Hepatology. 1992. Vol. 16. P. 60.
108. Rozga J. Liver support technology – an update // Xenotransplantation. 2006. Vol. 13. P. 380–389.
109. Safety observations in phase I clinical evaluation of the Excorp Medical Bioartificial Liver Support System after the first four patients / G. V. Mazariegos// ASAIO J. 2001. Vol. 47. P. 471–475.
110. Schäffler A., Büchler C. Concise review: adipose tissue-derived stromal cells-basic and clinical implications for novel cell-based therapies // Stem. Cells. 2007. Vol. 25. P. 818–827.
111. Schmelzer E., Wauthier E., Reid L. M. The phenotypes of pluripotent human hepatic progenitors // Stem. Cells. 2006. Vol. 24. P. 1852–1858.
112. Seghatchian J., de Sousa G. An overview of unresolved inherent problems associated with red cell transfusion and potential use of artificial oxygen carriers and ECO-RBC: current status/future trends // Transfus. Apher. Sci. 2007. Vol. 37. P. 251–259.
113. Separation of parenchymal liver cells using a lactosesubstituted styrene polymer substratum / T. Akaike// J. Bioact. Compat. Polym. 1989. Vol. 4 (51).
114. Shi L. L., Liu F. P., Wang D. W. Transplantation of human umbilical cord blood mesenchymal stem cells improves survival rates in a rat model of acute hepatic necrosis // Am. J. Med. Sci. 2011. Vol. 342. P. 212–217.
115. Strain A. J., Neuberger J. M. A bioartificial liver – state of the art // Science. 2002. Vol. 295. P. 1005–1009.
116. TECA hybrid artificial liver support system in treatment of acute liver failure / Y. L. Xue// World J. Gastroenterol. 2001. Vol. 7. P. 826–829.
117. The HepaRG cell line is suitable for bioartificial liver application / R. Hoekstra// Int. J. Biochem. Cell. Biol. 2011. Vol. 43. P. 1483–1489.
118. The Hepatix extracorporeal liver assist device: initial clinical experience / N. L. Sussman// Artif. Organs. 1994. Vol. 18. P. 390–396.
119. The promotion of hepatic maturation of human pluripotent stem cells in 3D co-culture using type I collagen and Swiss 3T3 cell sheets / Y. Nagamoto// Biomaterials. 2012. Vol. 33. P. 4526–4534.
120. The significant improvement of survival times and pathological parameters by bioartificial liver with recombinant HepG2 in porcine liver failure model / S. Enosawa// Cell. Transplant. 2006. Vol. 15. P. 873–880.
121. Toward a bioartificial drug metabolizing system: Gel immobilized liver cell microsomes / E. Denti// Trans. Am. Soc. Artif. Intern. Organs. 1976. Vol. 22. P. 693–700.
122. Transdifferentiation of adipose-derived stem cells into hepatocytes: a new approach / J. Lue// Liver Int. 2010. Vol. 30. P. 913–922.
123. Transplantation of human amnion epithelial cells reduces hepatic fibrosis in immunocompetent CCl4-treated mice / U. Manuelpillai// Cell. Transplant. 2010. Vol. 19. P. 1157–1168.
124. Use of a rotary bioartificial liver in the differentiation of human liver stem cells / V. Fonsato// Tissue. Eng. Part. C. Methods. 2010. Vol. 16. P. 123–132.
125. Use of primary human liver cells originating from discarded grafts in a bioreactor for liver support therapy and the prospects of culturing adult liver stem cells in bioreactors: a morphologic study / J. C. Gerlach// Transplantation. 2003. Vol. 76. P. 781–778.
126. Zaehres H., Schöler H. R. Induction of pluripotency: from mouse to human // Cell. 2007. Vol. 131. P. 834–835.